Professor of Pediatrics Director of Neuro-oncology, UPMC Children's Hospital of Pittsburgh
Broniscer was recruited to the University of Pittsburgh School of Medicine in August 2017 as a Professor of Pediatrics and Director of Pediatric Neuro-Oncology. He graduated from the São Paulo University Medical School in December 1989, where he also completed a two-year pediatric residency and an eighteen-month Pediatric Hematology-Oncology training. Broniscer completed a two-year Pediatric Hematology-Oncology and a one-year Neuro-Oncology fellowship at St. Jude Children’s Research Hospital, Memphis, TN from August 1993 until June 1996. Broniscer also completed additional neuro-oncology fellowships at New York University and Johns Hopkins Hospital. He then joined the faculty of St. Jude Children’s Research Hospital where he was a member of the Department of Oncology, Division of Neuro-Oncology from July 2002 until July 2017.
Broniscer has focused his clinical activities on the care of infants, children, adolescents, and young adults with central nervous system (CNS) cancers. His research has focused on developing clinical trials and increasing the understanding of molecular characteristics for high-grade gliomas (HGG) and diffuse intrinsic pontine gliomas (DIPGs), two of the deadliest pediatric CNS tumors. Broniscer’s interest have also focused on other CNS cancers including atypical teratoid rhabdoid tumors (ATRTs) and on understanding genetic predisposition to CNS cancers.
UPMC Children's Hospital of Pittsburgh
Landscape of Tumor-infiltrating T cell Repertoire of Pediatric Brain Tumors
Understanding the incidence and classification of T cell receptors of pediatric brain tumors is necessary to develop new therapies. Using data from the Pediatric Brain Tumor Atlas, researchers seek to better understand the tumor cellular immune system.
All Brain Tumor Types